🩹 H. Pylori Triple/Quadruple Therapy Simulator
This simulator models eradication therapy for H. pylori, including triple or quadruple regimens with proton pump inhibitors (PPIs), amoxicillin, clarithromycin, and bismuth, as well as resistance to antibiotics and the percentage of eradication.
H. Pylori Colonizes the Gastric Mucosa
H. pylori burrows through stomach mucus to reach the epithelial surface.
- ~50%: Global prevalence (placeholder statistic)
- Helical: Shape (flagellated motility)
- Mucus layer: Niche (urease neutralizes acid)
- Ulcer/cancer: Outcome risk (placeholder statistic)
Colonization mechanism
Short placeholder text on flagellar motility and urease-driven acid neutralization.
PPI + Amoxicillin + Clarithromycin
Standard triple therapy combines acid suppression with two antibiotics.
- 14 days: Regimen length (placeholder statistic)
- ~85%: Historic success (placeholder statistic)
- Clarithromycin: Key weakness (resistance-sensitive)
- Acid suppression: PPI role (boosts antibiotic activity)
How triple therapy works
Short placeholder text describing combined antibiotic and acid-suppression action.
Clarithromycin Resistance Undermines Triple Therapy
Rising resistance rates sharply cut triple therapy success.
- 23S rRNA: Resistance driver (point mutations)
- >15%: Threshold concern (placeholder statistic)
- High: Regional variance (placeholder statistic)
- Regimen failure: Consequence (placeholder statistic)
Resistance mechanism
Short placeholder text on ribosomal mutation blocking clarithromycin binding.
Bismuth Quadruple Therapy Alternative
Bismuth, metronidazole, tetracycline and a PPI bypass clarithromycin resistance.
- 10-14 days: Regimen length (placeholder statistic)
- ~90%: Success rate (placeholder statistic)
- Low: Resistance dependence (placeholder statistic)
- High-resistance areas: Use case (placeholder statistic)
Why quadruple therapy works
Short placeholder text on bismuth's multi-mechanism bactericidal action.
Confirming Eradication After Treatment
Urea breath or stool antigen testing verifies successful eradication.
- Urea breath: Test type (placeholder statistic)
- 4+ weeks: Wait period (post-treatment)
- High: Accuracy (placeholder statistic)
- Switch regimen: Retreat if failed (placeholder statistic)
Confirmation protocol
Short placeholder text on retesting timing and next-line therapy choice.
This simulator models eradication therapy for H. pylori, including triple or quadruple regimens with proton pump inhibitors (PPIs), amoxicillin, clarithromycin, and bismuth, as well as resistance to antibiotics and the percentage of eradication.
2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install